Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma
NCT07612098Phase 2Not yet recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jul 2026
- Primary completion
- Dec 2031
- Countries
- 1
01
Overview
A Phase 2 trial of penpulimab in soft tissue sarcoma (STS), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
penpulimab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT07612098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07612098.